Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

Completed · Phase 4

Conditions studied: Kidney Transplantation

In brief

This multicentre randomized, controlled trial (RCT) compared renal allograft histology and function in subjects treated with Tacrolimus + MMF + prednisone undergoing early protocol biopsies and treatment of subclinical rejection versus a non-protocol biopsy control group.

Key facts

Study ID
NCT00885820
Run by
Astellas Pharma Inc
People needed
240
Starts
2001-09-01
Expected to finish
2006-01-01
Last updated by the study team
2014-09-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.